CONNECT WITH US:
Oct 14, 2020 13:00 JST
Broncus Closes Series C Financing
Funds Will Support Further Development of Interventional Technologies for Navigation and Treatment of Diseases Across the Lung
HONG KONG, Oct 14, 2020 - (ACN Newswire) - Broncus Holding Company ("Broncus"), a global leader in diagnostic and therapeutic technology for lung diseases, today announced the closing of a Series C round of funding led by Lake Bleu Capital, and including Baidu Capital, the venture arm of one of the world's largest Internet and data science companies, Ascendum Capital, CNCB Capital and DCP Capital, along with previous investor Qiming Venture Capital.
The funds will be used to further develop markets and technology across lung cancer, emphysema and other important lung diseases. Efforts will include expanding global market adoption of the Archimedes Virtual Bronchoscopic Navigation System combining Fused Fluoroscopy, real-time bronchoscopy and virtual bronchoscopic navigation for 3D views and access to nodules anywhere in the lungs; expanded commercial adoption and global clinical studies of the InterVapor System for Bronchoscopic Thermal Vapor Ablation (BTVA) used in emphysema; U.S. and European studies of the EMPOWER RF Catheter used in Bronchoscopic Radiofrequency Ablation (BRFA); and further development of next-generation RF technology to precisely treat lung nodules.
Zhan Guowei, CEO of Broncus, said, "In recent years, medical device leaders such as Medtronic and Johnson & Johnson have invested in the market development of technologies for lung disease, which validates our forward-looking vision to focus exclusively on the diagnosis and treatment of diseases in the lung. Securing investors such as Lake Bleu Capital, Baidu Capital and Intuitive Surgical further supports our strategy to 'own' the lung when it comes to diagnosis and treatment. Our breakthrough navigation technology is enabling us to accelerate the development and commercialization of precise interventional technologies for diagnosis and treatment in order to improve options for patients with lung diseases and the physicians that care for them."
Dr. Li Bin, founder of Lake Bleu Capital, said: "Broncus is Lake Bleu's major investment in the medical device sector this year because they are addressing a large and unmet need globally in the diagnosis and treatment of lung diseases. Their world-leading Archimedes lung navigation technology is supported with robust data and uniquely helps physicians accurately locate and reach targeted lesions, which will open the door to new and exciting interventional lung therapies. We believe that Broncus is well positioned to lead the world in providing less invasive methods to diagnose and treat lung disease broadly."
Broncus recently announced a new strategic partnership with Olympus Europa to exclusively distribute Broncus Medical's Archimedes Planner and Archimedes Lite Virtual Bronchoscopic Navigation (VBN) system in several European countries.
Early investors in the company include Intuitive Surgical, an early pioneer and global technology leader in minimally invasive, robotic-assisted surgery.
About Broncus Holding Company
Broncus is dedicated to the development of diagnostic and therapeutic technology for lung disease. Founded in 2012, the company's primary technology platforms focus on the diagnosis of lung cancer and the treatment of emphysema. Its lung cancer portfolio includes the Archimedes System, Archimedes Planner, LungPoint Virtual Bronchoscopic Navigation (VBN) System, LungPoint Planner and FleXNeedle.
The Archimedes System has been cleared by the FDA (U.S.), CE (Europe) and NMPA (China) and had broad patent protection globally. The InterVapor System has received the CE Mark.
About Lake Bleu Capital
Lake Bleu Capital is an investment platform that specializes in healthcare in Asia/Greater China. As one of the largest healthcare public equity funds in Asia, the USD public equity fund under Lake Bleu Capital has won multiple industry-leading performance awards for the region of Asia ex-Japan. Meanwhile, Lake Bleu Capital has also focused on private equity investments in the Chinese healthcare industry, successfully completing multiple investments in flagship innovative companies across different healthcare subsectors.
Shirley Deng Email:
Sectors: Daily Finance, BioTech, Healthcare & Pharm, Venture Capital
Copyright ©2020 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Mitsubishi Shipbuilding Receives Approval in Principle for LNG Fuel Gas Supply System from Bureau Veritas
Oct 19, 2020 19:07 JST
Supercomputer Fugaku Wins the "Minister of Internal Affairs and Communications Award" at CEATEC 2020 ONLINE
Oct 19, 2020 18:49 JST
Toyota's GR Yaris Makes Its Dynamic Debut at the Goodwood Speedweek
Oct 19, 2020 18:41 JST
Fujitsu Commences Full-Scale Operation of HOKUSAI - SailingShip, RIKEN's New Data Science Infrastructure
Oct 19, 2020 10:39 JST
New ECLIPSE CROSS Reveals Radical New Styling and Expands Plug-In Hybrid Option
Oct 19, 2020 09:45 JST
Honda Announces Completion of the Tender Offer for Shares in Keihin, Showa and Nissin
Oct 16, 2020 17:16 JST
Showa Denko Markets PNVA(TM) 'GE191 Series' for Use as Binder to Form Heat-resisting Ceramic Layer in Separators for LIBs
Oct 16, 2020 16:00 JST
Eisai: Supplementary New Drug Applications for Anti-Epileptic Drug Fycompa as Monotherapy for Partial-Onset Seizures
Oct 16, 2020 13:44 JST
Fujitsu Verifies Effectiveness of Private 5G in Manufacturing Sites in Collaboration with Microsoft Japan
Oct 16, 2020 11:33 JST
Hitachi Acquired Additional Shares to Hold Majority of Shares of Yungtay, Elevator Company Based in Taiwan
Oct 15, 2020 17:41 JST
Mitsubishi Power Signs MOU with Indonesia's PLN Group and Bandung Institute of Technology (ITB) on Joint Policy Proposal to Promote Biomass Co-firing at Thermal Power Plants in Indonesia
Oct 15, 2020 12:06 JST
Hitachi ABB Power Grids Wins $6.6 Million Projects to Digitalize High-Speed Rail in the UK
Oct 14, 2020 17:48 JST
MHI Group Undertakes Investment in HydrogenPro of Norway, Leading Producer of Advanced Electrolyzers
Oct 14, 2020 15:33 JST
Toyota: Launch of a Preparatory Committee for "Japan Hydrogen Association (JH2A)"
Oct 14, 2020 14:06 JST
Fujitsu Accelerates Digital Transformation at Mizuho Bank Branches with Innovative Tablet Solution
Oct 14, 2020 12:58 JST
Fujitsu and PeptiDream Achieve Milestone in Joint Research for Peptide Drug Candidates with High-Speed, High-Precision Exploration Technology
Oct 13, 2020 17:04 JST
Fujitsu Commences Joint Research with World-Leading Institutions for Innovations in Quantum Computing
Oct 13, 2020 16:41 JST
Hitachi ABB Power Grids and Tensio TN AS to deliver Norway's First Fully Digital, Eco-efficient Substation
Oct 13, 2020 16:25 JST
Toyota: Heavy-Duty Fuel Cell Electric Truck Verification Tests to Start in Spring 2022
Oct 13, 2020 15:22 JST
DENSO Developed New Generation Battery-Monitoring Integrated Circuit for Lithium-ion Batteries, a Key component of Battery ECUs
Oct 13, 2020 11:54 JST
More Latest Release >>